Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis

Romero, Rodrigo, Sayin, Volkan I, Davidson, Shawn M, Bauer, Matthew R, Singh, Simranjit X, LeBoeuf, Sarah E, Karakousi, Triantafyllia R, Ellis, Donald C +20 more·2017·Nature Medicine

DOI 10.1038/nm.4407

Cited by (664)

Items 201–300 of 664

Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer
Hiroki Sekine, Hozumi Motohashi · 2021 · Cancers
Decoding the interplay between genetic and non-genetic drivers of metastasis
Panagiotis Karras, James R. Black, Nicholas McGranahan, Jean‐Christophe Marine · 2024 · Nature
“Keaping” a lid on lung cancer: the Keap1-Nrf2 pathway
Sarah A. Best, Kate D. Sutherland · 2018 · Cell Cycle
Towards quantitative and multiplexed in vivo functional cancer genomics
Ian P. Winters, Christopher W. Murray, Monte M. Winslow · 2018 · Nature Reviews Genetics
Exploiting metabolic vulnerabilities of Non small cell lung carcinoma
Blanca Majem, Ernest Nadal, Cristina Muñoz‐Pinedo · 2019 · Seminars in Cell and Developmental Biology
Nicotinamide nucleotide transhydrogenase regulates mitochondrial metabolism in NSCLC through maintenance of Fe-S protein function
Nathan P. Ward, Yun Pyo Kang, Aimee Falzone, Theresa A. Boyle, Gina M. DeNicola · 2020 · The Journal of Experimental Medicine
Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders
Tao Yu Wan, Ping Yuan · 2020 · Advanced Drug Delivery Reviews
Nuclear factor erythroid 2-related factor 2 as a treatment target of kidney diseases
Marie Ito, Tetsuhiro Tanaka, Masaomi Nangaku · 2019 · Current Opinion in Nephrology & Hypertension
Metabolic determinants of cellular fitness dependent on mitochondrial reactive oxygen species
Hyewon Kong, Colleen R. Reczek, Gregory Scott McElroy, Elizabeth M. Steinert, Tim Wang, David M. Sabatini, Navdeep S. Chandel · 2020 · Science Advances
REDD1 loss reprograms lipid metabolism to drive progression of RAS mutant tumors
Shuxi Qiao, Siang‐Boon Koh, Varunika Vivekanandan, Devika Salunke, Krushna Chandra Patra, Elma Zaganjor, Kenneth N. Ross, Yusuke Mizukami, Sarah Jeanfavre, Athena L. Chen et al. · 2020 · Genes & Development
PPIA dictates NRF2 stability to promote lung cancer progression
Weiqiang Lü, Jiayan Cui, Wanyan Wang, Qian Hu, Yun Xue, Xi Liu, Ting Gong, Yiping Lu, Hui Ma, Xinyu Yang et al. · 2024 · Nature Communications
NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling
Sachin Kumar Verma, David Crawford, Ali Khateb, Yongmei Feng, Eduard A. Sergienko, Gaurav Pathria, Chen-Ting Ma, Steven H. Olson, David A. Scott, Rabi Murad et al. · 2022 · Nature Cell Biology
Tumor Cells and Cancer-Associated Fibroblasts: An Updated Metabolic Perspective
Géraldine Gentric, Fatima Mechta‐Grigoriou · 2021 · Cancers
Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
DeBlasi, Janine M., Falzone, Aimee, Caldwell, Samantha, Prieto-Farigua, Nicolas, Prigge, Justin R., Schmidt, Edward E., Chio, Iok In Christine, Karreth, Florian A., DeNicola, Gina M. · 2023 · Cancer Research
Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells
Yoann Daniel, Elise Lelou, Caroline Aninat, Anne Corlu, Florian Cabillic · 2021 · Cancers
The role of branched chain amino acids metabolic disorders in tumorigenesis and progression
Jingtong Wang, Wei Wang, Feng Zhu, Qiuhong Duan · 2022 · Biomedicine & Pharmacotherapy
Reductive stress in cancer: coming out of the shadows
Maolin Ge, Thales Y. Papagiannakopoulos, Liron Bar‐Peled · 2023 · Trends in cancer
Nitric Oxide Engages an Anti-inflammatory Feedback Loop Mediated by Peroxiredoxin 5 in Phagocytes
Daniel B. Graham, Guadalupe J. Jasso, Amanda Mok, Gautam Goel, Aylwin Ng, Raivo Kolde, Mukund Varma, John G. Doench, David E. Root, Clary B. Clish et al. · 2018 · Cell Reports
Metabolic landscape of head and neck squamous cell carcinoma informs a novel kynurenine/Siglec‐15 axis in immune escape
Xin‐Yu Zhang, Jianbo Shi, Shufang Jin, Ruijie Wang, Mingyu Li, Zhiyuan Zhang, Xi Yang, Hailong Ma · 2024 · 癌症：英文版
Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy
Nai-Yun Sun, Muh‐Hwa Yang · 2020 · Frontiers in Oncology
Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers
Ramachandran Rashmi, Kay Jayachandran, Jin Zhang, Vishnu Menon, Naoshad Muhammad, Michael C. Zahner, Fiona Ruiz, Sisi Zhang, Kevin Cho, Yuting Wang et al. · 2020 · Molecular Cancer Therapeutics
Targeted inhibition of glutamine metabolism enhances the antitumor effect of selumetinib in KRAS-mutant NSCLC
Meng Xia, Xuena Li, Yao Diao, Bulin Du, Yaming Li · 2020 · Translational Oncology
The KEAP1-NRF2 System and Esophageal Cancer
Wataru Hirose, Hiroyuki Oshikiri, Keiko Taguchi, Masayuki P. Yamamoto · 2022 · Cancers
Understanding the Contribution of Lactate Metabolism in Cancer Progress: A Perspective from Isomers
Ming Cai, Jian Wan, Keren Cai, Haihan Song, Yujiao Wang, Wanju Sun, Jingyun Hu · 2022 · Cancers
Disulfidptosis, A Novel Cell Death Pathway: Molecular Landscape and Therapeutic Implications
Qiuyang Gu, Yumei An, Mingyuan Xu, Xinqi Huang, Xueshi Chen, Xianzhe Li, Haiyan Shan, Mingyang Zhang · 2024 · Aging and Disease
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
Mudasir A. Kumar, Sana Khurshid Baba, Inamu Rashid Khan, Mohd Shahnawaz Khan, Fohad Mabood Husain, Saheem Ahmad, Mohammad Haris, Mayank Singh, Ammira Al‐Shabeeb Akil, Muzafar Ahmad Macha et al. · 2025 · MedComm
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy
Zhengyu Jiang, Mengchen Lu, Qidong You · 2018 · Journal of Medicinal Chemistry
On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma
Colin R. Lindsay, Marina Chiara Garassino, Ernest Nadal, Katarina Öhrling, Matthias Scheffler, Julien Mazières · 2021 · Lung Cancer
Nano‐Strategies for Lignin Biomaterials toward Cancer Therapy
Thenapakiam Sathasivam, Kai Jing, Sigit Sugiarto, Yong Yu, Xiang Yun Debbie Soo, Qiang Zhu, Jasmeen S. Merzaban, Dan Kai · 2023 · Advanced Healthcare Materials
Unravelling cysteine-deficiency-associated rapid weight loss
Alan Varghese, Ivan Gusarov, Begona Gamallo‐Lana, Daria Dolgonos, Yatin Mankan, Ilya Shamovsky, Mydia Phan, Rebecca Jones, Maria Gomez-Jenkins, Eileen White et al. · 2025 · Nature
Metabolites as agents and targets for cancer immunotherapy
Marcel P. Trefny, Guido Kroemer, Laurence Zitvogel, Sebastian Kobold · 2025 · Nature Reviews Drug Discovery
Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras–Driven Tumor Growth or Metastasis
Jonathan M. Ghergurovich, Mark Esposito, Zihong Chen, Joshua Z. Wang, Vrushank Dharmesh Bhatt, Taijin Lan, Eileen White, Yibin Kang, Jessie Yanxiang Guo, Joshua D. Rabinowitz · 2020 · Cancer Research
NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer
Liam Baird, Masayuki P. Yamamoto · 2020 · Molecular and Cellular Biology
Multifaceted Roles of the KEAP1–NRF2 System in Cancer and Inflammatory Disease Milieu
Harit Panda, Huaichun Wen, Mikiko Suzuki, Masayuki P. Yamamoto · 2022 · Antioxidants
Impact of KRAS mutation on the tumor microenvironment in colorectal cancer
Yiru Zhou, Yeye Kuang, Chan Wang, Yijian Yu, Lijuan Pan, Xiaotong Hu · 2024 · International Journal of Biological Sciences
KEAP1/NRF2 (NFE2L2) mutations in NSCLC – Fuel for a superresistant phenotype?
Wolfram C. M. Dempke, Martin Reck · 2021 · Lung Cancer
Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer
Shannon S. Zhang, Misako Nagasaka · 2021 · Lung Cancer Targets and Therapy
The Tumor Suppressor Kinase LKB1: Metabolic Nexus
Mohammed Bourouh, Paola A. Marignani · 2022 · Frontiers in Cell and Developmental Biology
Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer
Xinlu Han, Deyu Wang, Yang Liao, Ning Wang, Jianliang Shen, Jinghan Wang, Lei Zhang, Li Chen, Shenglan Gao, Wei‐Xing Zong et al. · 2024 · Proceedings of the National Academy of Sciences
Mutational Activation of the NRF2 Pathway Upregulates Kynureninase Resulting in Tumor Immunosuppression and Poor Outcome in Lung Adenocarcinoma
Johannes Francois Fahrmann, Ichidai Tanaka, Ehsan Irajizad, Xiangying Mao, Jennifer B. Dennison, Eunice N. Murage, Julian P Casabar, Jeffrey Mayo, Qian Peng, Müge Çeliktaş et al. · 2022 · Cancers
Genetic alterations of Keap1 confers chemotherapeutic resistance through functional activation of Nrf2 and Notch pathway in head and neck squamous cell carcinoma
Syed Shahidul Islam, Khawlah Qassem, Shafiqul Islam, Rashed Rezwan Parag, Mohammed Z. Rahman, Walid A. Farhat, Herman Yeger, Abdelilah Aboussekhra, Bedri Karakas, Abu Shadat Mohammod Noman · 2022 · Cell Death and Disease
Impacts of NRF2 activation in non–small‐cell lung cancer cell lines on extracellular metabolites
Daisuke Saigusa, Ikuko N. Motoike, Sakae Saito, Michael Zorzi, Yuichi Aoki, Hiroshi Kitamura, Mikiko Suzuki, Fumiki Katsuoka, Hirofumi Ishii, Kengo Kinoshita et al. · 2019 · Cancer Science
Simultaneous Pharmacologic Inhibition of Yes‐Associated Protein 1 and Glutaminase 1 via Inhaled Poly(Lactic‐co‐Glycolic) Acid–Encapsulated Microparticles Improves Pulmonary Hypertension
Abhinav P. Acharya, Ying Margie Tang, Thomas Bertero, Yi‐Yin Tai, Lloyd D. Harvey, Chen-Shan Chen Woodcock, Wei Sun, Ricardo Pineda, Nilay Mitash, Mélanie Königshoff et al. · 2021 · Journal of the American Heart Association
E3 ligase TRIM15 facilitates non-small cell lung cancer progression through mediating Keap1-Nrf2 signaling pathway
Manman Liang, Lijing Wang, Zhengui Sun, Xingwu Chen, Hanli Wang, Lilong Qin, Wenying Zhao, Biao Geng · 2022 · Cell Communication and Signaling
Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress
Yongquan Tang, Zhe Zhang, Yan Chen, Siyuan Qin, Li Zhou, Wei Gao, Zhisen Shen · 2022 · Antioxidants
New Insights into Oxidative and Reductive Stress Responses and Their Relation to the Anticancer Activity of Selenium-Containing Compounds as Hydrogen Selenide Donors
Agnieszka Krakowiak, Sylwia Pietrasik · 2023 · Biology
Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes
José Manuel Matés, José Angel Campos-Sandoval, Juan de los Santos-Jiménez, Juan A. Segura, Francisco José Alonso, Javier Márquez · 2019 · Current Medicinal Chemistry
High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro
Laura Torrente, Gunjit Maan, Asma O.M. Rezig, Jean A. Quinn, Angus W. Jackson, Andrea Grilli, Laura Casares, Ying Zhang, Evgeny Kulesskiy, Jani Saarela et al. · 2020 · Biomolecules
The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas
Baharia Mograbi, Simon Heeke, Paul M Hofman · 2021 · Diagnostics
The multifaceted role of NRF2 in cancer progression and cancer stem cells maintenance
Bo-Hyun Choi, Jin Myung Kim, Mi‐Kyoung Kwak · 2021 · Archives of Pharmacal Research
Biological insights in non-small cell lung cancer
Rafael Rosell, Anisha S Jain, Jordi Codony‐Servat, Eloisa Jantus Lewintre, Blake Morrison, Jordi G Barretina, María González‐Cao · 2023 · Cancer Biology and Medicine
Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC
Biagio Ricciuti, Marina Chiara Garassino · 2024 · Journal of Thoracic Oncology
CRISPR/Cas9 for overcoming drug resistance in solid tumors
Ali Saber, Bin Liu, Pirooz Ebrahimi, Hidde J. Haisma · 2019 · DARU Journal of Pharmaceutical Sciences
N‐acetyl‐l‐tyrosine is an intrinsic triggering factor of mitohormesis in stressed animals
Takashi Matsumura, Outa Uryu, Fumikazu Matsuhisa, Keiji Tajiri, Hitoshi Matsumoto, Yoichi Hayakawa · 2020 · EMBO Reports
Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma
Xinyu He, Yubing Zhou, Wenjing Chen, Xiaokun Zhao, Lina Duan, Hao Zhou, Mingzhu Li, Yu Yin, Jimin Zhao, Yaping Guo et al. · 2023 · Oncogene
SLC7A11 as a bridge between ferroptosis and disulfidptosis: a promising target for tumor treatment
Hui Qiu, Jing Liu, Nan Shao, Juanjuan Zhao, Chao Chen, Yuanye Jiang, Xu Zhao, Lin Xu · 2025 · Cell Communication and Signaling
Cancer Stem Cells: Metabolic Characterization for Targeted Cancer Therapy
Jasmeet Kaur, Shalmoli Bhattacharyya · 2021 · Frontiers in Oncology
ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer
Vinee Purohit, Lidong Wang, Huibin Yang, Jiufeng Li, Gina M. Ney, Erica R. Gumkowski, Akash J. Vaidya, Annie Wang, Amit Bhardwaj, Ende Zhao et al. · 2021 · Genes & Development
Ferroptosis in osteosarcoma: A promising future
Xiang Liu, Shaowen Du, Shengdong Wang, Kaishan Ye · 2022 · Frontiers in Oncology
Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype
Steffanus Pranoto Hallis, Jin Myung Kim, Mi‐Kyoung Kwak · 2023 · Molecules and Cells
Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non–Small Cell Lung Cancer
Xiameng Gai, Yingluo Liu, Xiaojing Lan, Luoyi Chen, Tao Yuan, Jun Xu, Yize Li, Ying Zheng, Yiyang Yan, Liya Yang et al. · 2024 · Cancer Research
Metabolic Signaling Cascades Prompted by Glutaminolysis in Cancer
Raj Shah, Suzie Chen · 2020 · Cancers
Inhibition of the ʟ-glutamine transporter ASCT2 sensitizes plasma cell myeloma cells to proteasome inhibitors
Monika K. Prełowska, Dawid Mehlich, M. Talha Ugurlu, Hanna Kędzierska, Aleksandra Cwiek, Artur Kośnik, Klaudia Kaminska, Anna A. Marusiak, Dominika Nowis · 2021 · Cancer Letters
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
Koraljka Gall‐Tros̆elj, Marko Tomljanović, Morana Jaganjac, Tanja Matijević Glavan, Ana Čipak Gašparović, Lidija Milković, Suzana Borović Šunjić, Brigitta Buttari, Elisabetta Profumo, Sarmistha Saha et al. · 2022 · Molecules
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228
Paul K. Paik, Pang‐Dian Fan, Besnik Qeriqi, Azadeh Namakydoust, Bobby Daly, Linda Su Hyun Ahn, Rachel Kim, Andrew J. Plodkowski, Ai Ni, Jason C. Chang et al. · 2022 · Journal of Thoracic Oncology
Cooperative nutrient scavenging is an evolutionary advantage in cancer
Gizem Guzelsoy, Setiembre D. Elorza, Manon Ros, Logan T. Schachtner, Makiko Hayashi, Spencer Hobson-Gutierrez, Parker Rundstrom, Julia S. Brunner, Ray Pillai, William E. Walkowicz et al. · 2025 · Nature
Inhibitor of Differentiation-1 Sustains Mutant KRAS -Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network
Marta Román, Inés López, Elizabeth Guruceaga, Iosune Baraibar, Margarita Ecay, María Collantes, Ernest Nadal, Adrián Vallejo, Silvia Cadenas, Marta Echavarri-de Miguel et al. · 2018 · Cancer Research
Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells
Yuta Hara, Yushi Minami, Soshi Yoshimoto, Natsumi Hayashi, Akitaka Yamasaki, Shiho Ueda, Kazue Masuko, Takashi Masuko · 2019 · Cancer Medicine
Metabolic Strategies for Inhibiting Cancer Development
Philippe Icard, Mauro Loi, Zherui Wu, Antonin Ginguay, Hubert Lincet, Edouard Robin, Antoine Coquerel, Diana Berzan, Ludovic Fournel, Marco Alifano · 2020 · Advances in Nutrition
Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition
Shin Hamada, Ryotaro Matsumoto, Yu Tanaka, Keiko Taguchi, Masayuki P. Yamamoto, Atsushi Masamune · 2021 · International Journal of Molecular Sciences
Targeting RAS mutants in malignancies: successes, failures, and reasons for hope
Hang Sheng Yang, Xinyi Zhou, Dongliang Fu, Chenqin Le, Jiafeng Wang, Quan Zhou, Xiangrui Liu, Ying Yuan, Kefeng Ding, Qian Xiao · 2022 · 癌症：英文版
Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma
Jianchun Duan, Yun Zhang, Ran Chen, Liang Liang, Yi Huo, Shun Lü, Jun Zhao, Chunhong Hu, Yuping Sun, Kunyu Yang et al. · 2023 · Cell Reports Medicine
Metabolic Remodeling as a Way of Adapting to Tumor Microenvironment (TME), a Job of Several Holders
Jacinta Serpa · 2020 · Advances in experimental medicine and biology
Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer
Jong-Su Kang, Le Ba Nam, Ok-Kyung Yoo, Young‐Sam Keum · 2020 · Biochemical Pharmacology
Glutamine deprivation induces ferroptosis in pancreatic cancer cells
Zhiwen Xiao, Shengming Deng, He Liu, Ruijie Wang, Yu Liu, Zhengjie Dai, Wenchao Gu, Quanxing Ni, Xianjun Yu, Chen Liu et al. · 2023 · Acta Biochimica et Biophysica Sinica
Mitochondria and Cancer
Timothy C. Kenny, Kıvanç Birsoy · 2024 · Cold Spring Harbor Perspectives in Medicine
Nf1 loss promotes Kras-driven lung adenocarcinoma and results in Psat1-mediated glutamate dependence
Wang, Xiaojing, Min, Shengping, Liu, Hongli, Wu, Nan, Liu, Xincheng, Wang, Tao, Li, Wei, Shen, Yuanbing, Wang, Hongtao, Qian, Zhongqing et al. · 2019 · EMBO Molecular Medicine
Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels
Lova Sun, Elizabeth A. Handorf, Yunyun Zhou, Hossein Borghaei, Charu Aggarwal, Jessica Ruth Bauman · 2024 · Lung Cancer
Metabolic Targeting of Cancer Stem Cells
Anna Mukha, Anna Dubrovska · 2020 · Frontiers in Oncology
Antioxidants Promote Intestinal Tumor Progression in Mice
Zhiyuan V. Zou, Kristell Le Gal, Ahmed Ezat El Zowalaty, Lara E. Pehlivanoglu, Viktor Garellick, Nadia Gul, Mohamed X. Ibrahim, Per‐Olof Bergh, Marcus Henricsson, Clotilde Wiel et al. · 2021 · Antioxidants
Comprehensive Profiling of Genomic and Transcriptomic Differences between Risk Groups of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
Talip Zengin, Tuğba Önal-Süzek · 2021 · Journal of Personalized Medicine
The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario
Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan · 2023 · Medical Oncology
Synergistic effect of glutathione and IgG4 in immune evasion and the implication for cancer immunotherapy
Weifeng Zhang, Yan Quan, Xiaonan Ma, Liting Zeng, Jirui Li, Shuqi Chen, Meng Su, Liangli Hong, Penghao Li, Hui Wang et al. · 2023 · Redox Biology
Discovery of a Thiadiazole–Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models
M. Raymond V. Finlay, Mark J. Anderton, Andrew Bailey, Scott Boyd, Joanna L. Brookfield, Ceri Cairnduff, Mark D. Charles, Anne Cheasty, Susan E. Critchlow, Janet D. Culshaw et al. · 2019 · Journal of Medicinal Chemistry
Cancer metabolism within tumor microenvironments
Sho Aki, Ryuichi Nakahara, Keisuke Maeda, Tsuyoshi Osawa · 2023 · Biochimica et Biophysica Acta (BBA) - General Subjects
Improving Drug Delivery of Micellar Paclitaxel against Non‐Small Cell Lung Cancer by Coloading Itraconazole as a Micelle Stabilizer and a Tumor Vascular Manipulator
Ling Zhang, Zhengsheng Liu, Chao Kong, Chun Liu, Kuan Yang, Huijun Chen, Jinfeng Huang, Feng Qian · 2018 · Small
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth
Caroline Contat, Pierre‐Benoit Ancey, Nadine Zangger, Silvia Sabatino, Justine Pascual, Stéphane Escrig, Louise Helene Søgaard Jensen, Christine Goepfert, Bernard Lanz, Mario G. Lepore et al. · 2020 · eLife
Characterization With KRAS Mutant Is a Critical Determinant in Immunotherapy and Other Multiple Therapies for Non-Small Cell Lung Cancer
Mo Shen, Rongbin Qi, Justin Ren, Dongqing Lv, Haihua Yang · 2022 · Frontiers in Oncology
Recent advances of the biological and biomedical applications of CRISPR/Cas systems
Yaya Wang, Huang Chun, Weiqin Zhao · 2022 · Molecular Biology Reports
DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome
Kayla Guidry, Varshini Vasudevaraja, Kristen E. Labbe, Hussein Mohamed, Jonathan Serrano, Brett W. Guidry, Michael DeLorenzo, Hua Zhang, Jiehui Deng, Soumyadip Sahu et al. · 2022 · Clinical Cancer Research
Glutathione Dynamics in the Tumor Microenvironment: A Potential Target of Cancer Stem Cells and T Cells
Y. Park, Eui Man Jeong · 2024 · International Journal of Stem Cells
Novel therapeutic strategy for cancer and autoimmune conditions: Modulating cell metabolism and redox capacity
Xing‐Xing Fan, Hudan Pan, Ying Li, Ruijin Guo, Elaine Lai‐Han Leung, Liang Liu · 2018 · Pharmacology & Therapeutics
Mutations in the Antioxidant KEAP1/NRF2 Pathway Define an Aggressive Subset of NSCLC Resistant to Conventional Treatments
Ernest Nadal, Ramón Palmero, Cristina Muñoz‐Pinedo · 2019 · Journal of Thoracic Oncology
Cullin 3 and Its Role in Tumorigenesis
Ruey‐Hwa Chen · 2020 · Advances in experimental medicine and biology
Emerging strategies to target cancer metabolism and improve radiation therapy outcomes
Martin Kery, Ioanna Papandreou · 2020 · British Journal of Radiology
Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
Elisa Caiola, Marika Colombo, Giovanna Sestito, Monica Lupi, Mirko Marabese, Roberta Pastorelli, Massimo Broggini, Laura Brunelli · 2020 · Cells
Health position paper and redox perspectives – Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases
Cuadrado, Antonio, Cazalla, Eduardo, Bach, Anders, Bathish, Boushra, Naidu, Sharadha Dayalan, DeNicola, Gina M., Dinkova-Kostova, Albena T., Fernández-Ginés, Raquel, Grochot-Przeczek, Anna, Hayes, John D. et al. · 2025 · Redox Biology
Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive Pancreatic Tumorigenesis
Ruowen Zhang, Xiaogang Peng, James Xianxing Du, Rebecca J. Boohaker, Igor L. Estevao, Brian I. Grajeda, Marc B. Cox, Igor Correia de Almeida, Weiqin Lu · 2023 · Cancer Research
Lipid-Based Nanocarriers for Targeted Gene Delivery in Lung Cancer Therapy: Exploring a Novel Therapeutic Paradigm
Anahita Beigi, Seyed Morteza Naghib, Amir Matini, Maryam Tajabadi, Mohammad Reza Mozafari · 2024 · Current Gene Therapy
The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
Narasimha Murthy Beeraka, Venugopal Reddy Bovilla, Shalini H. Doreswamy, Sujatha Puttalingaiah, Asha Srinivasan, SubbaRao V. Madhunapantula · 2021 · Cancers